Ireland - English - HPRA (Health Products Regulatory Authority)

rosemont pharmaceuticals ltd - clobazam - oral suspension - 1 milligram(s)/millilitre - benzodiazepine derivatives; clobazam - anxiolytics - it is indicated in adults for the short-term symptomatic treatment (2-4 weeks) only of anxiety that is severe, disabling or subjecting the individual to unacceptable distress. in treatment of anxiety states associated with affected disorders, perizam must only be used in conjunction with adequate treatments for the underlying disorder. in patients with schizophrenic or other psychotic illnesses, use of benzodiazepines is recommended only for short term symptomatic management of hyperarousal and agitation. benzodiazepines do not possess antipsychotic properties. perizam may be used as adjunctive therapy in epilepsy in adults or children over 6, if standard treatment with one or more anticonvulsants has failed.

Ireland - English - HPRA (Health Products Regulatory Authority)

rosemont pharmaceuticals ltd - clobazam - oral suspension - 2 milligram(s)/millilitre - benzodiazepine derivatives; clobazam - anxiolytics - it is a 1,5-benzodiazepine indicated in adults for the short-term symptomatic treatment (2-4 weeks) only of anxiety that is severe, disabling or subjecting the individual to unacceptable distress. in treatment of anxiety states associated with affected disorders, perizam must only be used in conjunction with adequate treatments for the underlying disorder. in patients with schizophrenic or other psychotic illnesses, use of benzodiazepines is recommended only for short term symptomatic management of hyperarousal and agitation. benzodiazepines do not possess antipsychotic properties. perizam may be used as adjunctive therapy in epilepsy in adults or children over 6, if standard treatment with one or more anticonvulsants has failed.

United Kingdom - English - myHealthbox

rosemont pharmaceuticals ltd - desloratadine - oral solution - 0.5mg/ml - antihistamines – h1 antagonist - it is indicated in adults, adolescents and children over the age of 1 year for the relief of symptoms associated with: - allergic rhinitis - urticaria

Ireland - English - HPRA (Health Products Regulatory Authority)

vale pharmaceuticals ltd - flucloxacillin sodium - pdr for soln inj/inf - 250 milligram - beta-lactamase resistant penicillins

Ireland - English - HPRA (Health Products Regulatory Authority)

vale pharmaceuticals ltd - flucloxacillin sodium - pdr for soln inj/inf - 500 milligram - beta-lactamase resistant penicillins

Ireland - English - HPRA (Health Products Regulatory Authority)

vale pharmaceuticals ltd - flucloxacillin sodium - pdr for soln inj/inf - 1000 milligram - beta-lactamase resistant penicillins

Ireland - English - HPRA (Health Products Regulatory Authority)

vale pharmaceuticals ltd - flucloxacillin sodium - pdr for soln inj/inf - 2000 milligram - beta-lactamase resistant penicillins

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspar pharmaceuticals ltd - paracetamol - oral tablet - 500mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspar pharmaceuticals ltd - aspirin - oral tablet - 300mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

reckitt benckiser healthcare (uk) ltd - ibuprofen - cutaneous gel - 50mg/1gram